Anbio Biotechnology Operating Expenses
Anbio Biotechnology (NNNN) reported Operating Expenses of $1.78 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-04-07
| Period end | Operating Expenses 12 month |
|---|---|
| 2025-12-31 | $1.78M 20-F · filed 2026-04-07 |
| 2024-12-31 | $3.89M 20-F · filed 2026-04-07 |
| 2023-12-31 | $1.40M 20-F · filed 2026-04-07 |
| 2022-12-31 | $2.37M 20-F · filed 2025-04-28 |